US equities markets engineered a major comeback after being hammered at the opening bell. The SPY ETF, which tracks the S&P 500, was down over 2% before reversing to become positive by the latter part of the session. The healthcare ETF XLV and the biotech ETF IBB both bounced back as well and were positive at the time this content was recorded. Meanwhile, Imprimis Pharmaceuticals (IMMY) rallied strongly due to an upgrade from Lake Street with a $10 price target. Here’s a recap.
Want to find out how Scott can give your summer trading a potential edge? Let’s see if you’re a fit for his program. Fill out this quick application to get started. Summer trading has historically been slow and relatively uneventful. Some might even call it boring. However, Scott Bauer believes it could be much different […]
Read Article
Charlie Moon joined Schwab Network to break down a live options trade on KLA Corp — a semiconductor equipment maker that just did something he’s been waiting for. Here’s the setup and exactly how he’s positioning.
Read Article
Scott Bauer already has four names on his radar to kick off summer trading… but he believes it could be much different this year. Scott was on Business First AM, where he highlighted the stocks that are on his radar, and the factors he believes could shape the market this summer. The analysis, insights, and […]
Read Article
Equities finished the holiday-shortened week with a more complicated message than the headline indexes suggested. The Dow Jones Industrial Average pushed to new records this week, helped by industrials and financials, while the broader market wrestled with a hawkish Federal Reserve, rising 2-year yields, and an increasingly narrow technology trade. The week’s major geopolitical headline was […]
Read Article
Major indices changed course in a meaningful way this past week, ending in the green despite significant initial volatility. For the week, the S&P 500, Dow and Nasdaq-100 all gained just under 1%. Headline whiplash about developments in the war between the U.S. and Iran ended with hope that an agreement is in the offing. […]
Read Article
SpaceX (SPCX) closed its first day of trading up 19 percent. The biggest IPO in market history is now public, and traders are already asking the same question: What’s next for SPCX? The hype was real, but Charlie Moon believes the more interesting story is just starting to unfold. He recorded a breakdown, with his […]
Read ArticleWe choose to let our members and students speak for themselves. We do not actively solicit testimonials, no compensation has been paid for any testimonial, and testimonials are not necessarily representative of the experience of all students. All monetary claims made in testimonials that you see depicted in our marketing material have been verified by Prosper Trading Academy and attested to by the members that have given them. Verified testimonials encompass “experience” reviews that highlight the personal experiences of working with our team and “performance” testimonials where we verify trading success of students who have enrolled in our programs.Given the broad reach of the internet, testimonials and reviews of our programs that we have not been able to verify can be found on various websites across the internet which are beyond our editorial control. While we do very much enjoy hearing positive things from our students and it is critical to our mission that everyone is satisfied with their journey with Prosper, we encourage you to take both verified and unverified testimonials for what they are.